Please provide your email address to receive an email when new articles are posted on . The FDA approved the device in October based on the results of this trial, he said. “The device visualizes the ...
The US Food and Drug Administration is alerting the public of a potentially high-risk device issue related to Rotarex Atherectomy Systems (Bard Peripheral Vascular) used in peripheral artery ...
WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results